Vicarious Surgical (RBOT) Gains from Investment Securities (2021 - 2025)

Vicarious Surgical (RBOT) has reported Gains from Investment Securities for 5 consecutive years, with -$40000.0 the latest figure, recorded in Q2 2025.

• In Q2 2025, Gains from Investment Securities rose 97.48% year-over-year to -$40000.0; the TTM figure through Jun 2025 stood at -$267000.0 (up 95.48% YoY), while the FY2024 annual figure was -$43000.0, up 99.17% from the prior year.
• Gains from Investment Securities retreated to -$40000.0 in Q2 2025 per RBOT's latest filing, from $93000.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $19.6 million in Q2 2021 and bottomed at -$17.6 million in Q2 2022.
• Historically, Gains from Investment Securities has averaged -$477433.3 across 5 years, with a median of -$40000.0 in 2025.
• Annual changes were most pronounced in 2023 — Gains from Investment Securities tumbled 254.81% — and 2024, when it jumped 102.93%.
• Vicarious Surgical's Gains from Investment Securities stood at $19.6 million in 2021, then slumped by 144.51% to -$8.7 million in 2022, then jumped by 82.94% to -$1.5 million in 2023, then surged by 69.18% to -$458000.0 in 2024, then soared by 91.27% to -$40000.0 in 2025.
• Business Quant data shows RBOT's Gains from Investment Securities at -$40000.0 in Q2 2025, $93000.0 in Q1 2025, and -$458000.0 in Q4 2024.